ALTO vs MRNA · P/E 13, rev $470.4M vs rev $145.0M
Alto Ingredients Inc (ALTO) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Alto Ingredients Inc (ALTO) is a specialty chemicals company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported ALTO revenue for 2026-06-30 was $470.4M. Net income was $16.0M. ALTO currently screens at market cap $383.6M and trailing P/E 13.4.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ALTO currently screens at market cap $383.6M and trailing P/E 13.4. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ALTO and MRNA stock pages for the full models.
Not investment advice.